This topic contains a solution. Click here to go to the answer

Author Question: Recent medical school graduate Dr. Boykin is undertaking his psychiatry residency with Dr. Stone, an ... (Read 51 times)

s.tung

  • Hero Member
  • *****
  • Posts: 577
Recent medical school graduate Dr. Boykin is undertaking his psychiatry residency with Dr. Stone, an expert in repeated transcranial magnetic stimulation (rTMS). As the two doctors prepare for a clinical trial involving rTMS, Dr. Stone warns that rTMS can have negative effects on patients with a history of ____; therefore, these patients must be excluded from the study.
 
  a. depression
  b. bipolar disorder
  c. attention deficit hyperactivity disorder
  d. bipolar disorder

Question 2

A nonsurgical alternative to deep brain stimulation is repeated ____.
 
  a. ionic pulse stimulation
  b. cerebral current stimulation
  c. transcranial magnetic stimulation
  d. neuropenetrative laser stimulation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

johnharpe

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANSWER:
d

Answer to Question 2

ANSWER:
c




s.tung

  • Member
  • Posts: 577
Reply 2 on: Jun 19, 2018
Great answer, keep it coming :)


DylanD1323

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library